MSE
ROIV icon

MUFG Securities EMEA’s Roivant Sciences ROIV Stock Holding History

MUFG Securities EMEA’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-200,000
Closed -$5.54M – 597
2026
Q1 		$5.54M Sell
200,000
-292,000
-59% -$7.5M 0.08% 158
2025
Q4 		$10.7M Buy
+492,000
New +$9.71M 0.12% 133

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

MUFG Securities EMEA's ROIV Position: Q2 2026 in Review

MUFG Securities EMEA sold out of Roivant Sciences (ROIV) in Q2 2026, closing a stake of 200,000 shares — an estimated $5.54M sold.

MUFG Securities EMEA first reported a position in ROIV in Q4 2025 and held it in 2 quarters. The position peaked at $10.7M in Q4 2025. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • MUFG Securities EMEA reported no remaining Roivant Sciences position as of Q2 2026 after selling out during the quarter.
  • MUFG Securities EMEA sold 200,000 Roivant Sciences shares in Q2 2026, an estimated $5.54M.
  • MUFG Securities EMEA first reported a position in Roivant Sciences in Q4 2025 and held it in 2 quarters.
  • MUFG Securities EMEA's Roivant Sciences position peaked at $10.7M in Q4 2025.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on MUFG Securities EMEA's 13F filing for Q2 2026, filed 12 Aug 2026.